scholarly journals CONFRONTO TRA SISTEMI DIAGNOSTICI MOLECOLARI PER LA DEFINIZIONE DELLA VIRAL LOAD DI HCV: COBAS AMPLICOR MONITOR HCV 2.0,VERSANT B-DNA HCV 3.0, E COBAS TAQMAN HCV

2006 ◽  
Vol 21 (3) ◽  
Author(s):  
P. Ravanini ◽  
F. Milano ◽  
F. Caviglia ◽  
E. Grossini ◽  
A.M. Nicosia ◽  
...  
2015 ◽  
Vol 13 (4) ◽  
pp. 262-267 ◽  
Author(s):  
Ado Abubakar ◽  
Nicaise Ndembi ◽  
Obinna Ogbanufe ◽  
Auchi Inalegwu ◽  
Simi Wilson ◽  
...  

2010 ◽  
Vol 02 (03) ◽  
Author(s):  
Joseph Nkeze Dong Liang ◽  
Heather Adkins Richard Y. Zhao
Keyword(s):  
Hiv 1 ◽  

2015 ◽  
Vol 31 (4) ◽  
pp. 188-193 ◽  
Author(s):  
Yi-Ching Tung ◽  
Liang-Yin Ke ◽  
Po-Liang Lu ◽  
Kuei-Hsiang Lin ◽  
Su-Chen Lee ◽  
...  

2013 ◽  
Vol 187 (2) ◽  
pp. 248-250 ◽  
Author(s):  
Dominique Goedhals ◽  
Lesley E. Scott ◽  
Serena Moretti ◽  
Mark A. Cooper ◽  
Willem J.L. Opperman ◽  
...  

2017 ◽  
Vol 96 ◽  
pp. 49-53 ◽  
Author(s):  
Marc Wirden ◽  
Lucile Larrouy ◽  
Nadia Mahjoub ◽  
Eve Todesco ◽  
Florence Damond ◽  
...  
Keyword(s):  

PLoS ONE ◽  
2017 ◽  
Vol 12 (6) ◽  
pp. e0179316 ◽  
Author(s):  
Clement Zeh ◽  
Kenneth Ndiege ◽  
Seth Inzaule ◽  
Rebecca Achieng ◽  
John Williamson ◽  
...  

Author(s):  
Virginia M. Pierce ◽  
Jacqueline S. Eversley ◽  
Thuy K. Tran ◽  
Eric S. Rosenberg

AbstractBackground:Differences between the designs of hepatitis C virus (HCV) viral load assays can result in genotype-related variability in RNA quantification. We tested paired aliquots of plasma specimens from HCV-infected individuals using two versions (v1.0 and v2.0) of the Roche COBAS AmpliPrep/COBAS TaqMan HCV Test (CAP/CTM HCV) and noted variability between results for a subset of specimens; we then sought to determine whether discrepant results were more prevalent among specific HCV genotypes.Methods:Archived and prospectively-collected plasma samples from 114 unique patients were tested using CAP/CTM HCV v1.0 and v2.0. The HCV genotype result for each patient was determined by retrospectively reviewing laboratory records.Results:All (46/46) specimens with quantifiable viral loads from patients with genotype 1 or 2 infection had CAP/CTM HCV v1.0 and v2.0 results that were within 0.5 logConclusions:In patients infected with HCV genotype 3, sequential CAP/CTM HCV viral load results should be compared with caution and interpreted in the context of the specific assay version used.


Sign in / Sign up

Export Citation Format

Share Document